LeadIQ logo
Learn more at LeadIQ.com

Insights

Specialized R&D Intellipharmaceutics focuses on controlled-release and opioid abuse deterrent pharmaceuticals, presenting opportunities to offer tailored formulation and drug delivery solutions that enhance their product portfolio.

Partnership Potential The company's licensing and supply agreement with Mallinckrodt indicates openness to strategic collaborations, making it a prime prospect for partners interested in joint development or distribution deals.

Emerging Market Size With revenues ranging from one to ten million dollars and a relatively small team, Intellipharmaceutics represents a growing entity where targeted value propositions could accelerate their product development and manufacturing capacities.

Tech Infrastructure Utilizing cloud services, data analytics, and web presence tools suggests they value technological innovation, inviting opportunities to provide advanced digital, data management, or automation tools to improve R&D and operations.

Growth and Funding Having secured $3.1 million in funding and active operations, the company may seek additional investments or service providers to support expansion efforts in highly specialized pharmaceutical niches.

Similar companies to Intellipharmaceutics International

Intellipharmaceutics International Tech Stack

Intellipharmaceutics International uses 8 technology products and services including Google AdSense, Linkedin Insight Tag, Amazon Web Services, and more. Explore Intellipharmaceutics International's tech stack below.

  • Google AdSense
    Advertising
  • Linkedin Insight Tag
    Analytics
  • Amazon Web Services
    Cloud Hosting
  • WordPress
    Content Management System
  • MySQL
    Database
  • Google Maps
    Maps
  • PHP
    Programming Languages
  • Breadcrumb NavXT
    Web Platform Extensions

Media & News

Intellipharmaceutics International's Email Address Formats

Intellipharmaceutics International uses at least 1 format(s):
Intellipharmaceutics International Email FormatsExamplePercentage
FLast@intellipharmaceutics.comJDoe@intellipharmaceutics.com
97%
First@intellipharmaceutics.comJohn@intellipharmaceutics.com
3%

Frequently Asked Questions

Where is Intellipharmaceutics International's headquarters located?

Minus sign iconPlus sign iconIntellipharmaceutics International's main headquarters is located at 30 Worcester Road Etobicoke, Ontario m9w 5x2 Canada. The company has employees across 1 continents, including North America.

What is Intellipharmaceutics International's stock symbol?

Minus sign iconPlus sign iconIntellipharmaceutics International is a publicly traded company; the company's stock symbol is IPCIF.

What is Intellipharmaceutics International's official website and social media links?

Minus sign iconPlus sign iconIntellipharmaceutics International's official website is intellipharmaceutics.com and has social profiles on LinkedInCrunchbase.

How much revenue does Intellipharmaceutics International generate?

Minus sign iconPlus sign icon As of April 2026, Intellipharmaceutics International's annual revenue is estimated to be $5M.

What is Intellipharmaceutics International's SIC code NAICS code?

Minus sign iconPlus sign iconIntellipharmaceutics International's SIC code is 7299 - Miscellaneous Personal Services, Not Elsewhere Classified NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Intellipharmaceutics International have currently?

Minus sign iconPlus sign iconAs of April 2026, Intellipharmaceutics International has approximately 26 employees across 1 continents, including North America. Key team members include Vice President: P. N. Y.Vice President: S. F.Controller: F. S.. Explore Intellipharmaceutics International's employee directory with LeadIQ.

What industry does Intellipharmaceutics International belong to?

Minus sign iconPlus sign iconIntellipharmaceutics International operates in the Pharmaceutical Manufacturing industry.

What technology does Intellipharmaceutics International use?

Minus sign iconPlus sign iconIntellipharmaceutics International's tech stack includes Google AdSenseLinkedin Insight TagAmazon Web ServicesWordPressMySQLGoogle MapsPHPBreadcrumb NavXT.

What is Intellipharmaceutics International's email format?

Minus sign iconPlus sign iconIntellipharmaceutics International's email format typically follows the pattern of FLast@intellipharmaceutics.com. Find more Intellipharmaceutics International email formats with LeadIQ.

How much funding has Intellipharmaceutics International raised to date?

Minus sign iconPlus sign icon As of April 2026, Intellipharmaceutics International has raised $3.1M in funding. The last funding round occurred on Apr 22, 2021 for $3.1M.

When was Intellipharmaceutics International founded?

Minus sign iconPlus sign iconIntellipharmaceutics International was founded in 1998.

Intellipharmaceutics International

Pharmaceutical ManufacturingOntario, Canada11-50 Employees

At Intellipharmaceutics, we are engaged in the research, development and commercialization of pharmaceutical products, both novel and generic, with a particular emphasis in the controlled-release & opioid abuse deterrence space.

Intellipharmaceutics also operates a contract analytical services lab in Toronto that provides Methods Development, Validation & Transfer, Quality Control Testing, Stability Testing and Category 1 Abuse Deterrent Studies.

Intellipharmaceutics International is currently trading on the OTCQB and TSX (OTCQB: IPCIF; TSX: IPCI).

Section iconCompany Overview

Headquarters
30 Worcester Road Etobicoke, Ontario m9w 5x2 Canada
Website
intellipharmaceutics.com
SIC Code
7299 - Miscellaneous Personal Services, Not Elsewhere Classified
Stock Symbol
IPCIF
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1998
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $3.1M

    Intellipharmaceutics International has raised a total of $3.1M of funding over 3 rounds. Their latest funding round was raised on Apr 22, 2021 in the amount of $3.1M.

  • $1M$10M

    Intellipharmaceutics International's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $3.1M

    Intellipharmaceutics International has raised a total of $3.1M of funding over 3 rounds. Their latest funding round was raised on Apr 22, 2021 in the amount of $3.1M.

  • $1M$10M

    Intellipharmaceutics International's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    P. N. Y.
    Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. F.
    Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. S.
    Controller
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. L.
    Qc Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. Z.
    Research And Development Manager
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    A. M.
    Regulatory Affairs Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Y. K.
    Manager Business Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. B.
    Senior Associate -Qa & Compliance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    V. B.
    Processing Technologist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    Scientist
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.